Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer.
Ther Adv Med Oncol
; 12: 1758835919897546, 2020.
Article
en En
| MEDLINE
| ID: mdl-32064003
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
Idioma:
En
Año:
2020
Tipo del documento:
Article